ALSE — Alseres Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.315 | 0.099 | 0.163 | 0.897 | 0.321 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.388 | 0.209 | 0.168 | 0.9 | 0.325 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.106 | 0.048 | 0.002 | 0.001 | 0 |
Other Long Term Assets | |||||
Total Assets | 0.791 | 0.461 | 0.171 | 0.966 | 0.385 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.92 | 37.6 | 30.4 | 10.1 | 1.65 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 43.2 | 42.3 | 30.4 | 27.3 | 10.7 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -42.4 | -41.9 | -30.3 | -26.4 | -10.3 |
Total Liabilities & Shareholders' Equity | 0.791 | 0.461 | 0.171 | 0.966 | 0.385 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |